Porter D - Search Results

1

Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.

McInnes IB, Porter D, Murphy EA, Thomson EA, Madhok R, Hunter JA, Pullar T, Capell HA. McInnes IB, et al. Among authors: porter d. Ann Rheum Dis. 1996 May;55(5):328-30. doi: 10.1136/ard.55.5.328. Ann Rheum Dis. 1996. PMID: 8660109 Free PMC article. Clinical Trial.

2

Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count.

Porter DR, Marshall DA, Madhok R, Capell H, Sturrock RD. Porter DR, et al. Br J Rheumatol. 1992 Jan;31(1):71-2. doi: 10.1093/rheumatology/31.1.71. Br J Rheumatol. 1992. PMID: 1346096 No abstract available.

3

Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.

Porter D, Madhok R, Hunter JA, Capell HA. Porter D, et al. Ann Rheum Dis. 1992 Apr;51(4):461-4. doi: 10.1136/ard.51.4.461. Ann Rheum Dis. 1992. PMID: 1350192 Free PMC article. Clinical Trial.

4

Action of sodium aurothiomalate on erythrocyte membrane.

Campbell JM, Reglinski J, Smith WE, Porter D, Sturrock RD. Campbell JM, et al. Among authors: porter d. Ann Rheum Dis. 1992 Aug;51(8):969-71. doi: 10.1136/ard.51.8.969. Ann Rheum Dis. 1992. PMID: 1417122 Free PMC article.

5

Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.

Marshall D, Sturrock RD, Porter D, Capell HA. Marshall D, et al. Among authors: porter d. Thorax. 1992 Jan;47(1):67. doi: 10.1136/thx.47.1.67. Thorax. 1992. PMID: 1539154 Free PMC article. No abstract available.

6

The use of sulphasalazine as a disease modifying antirheumatic drug.

Porter DR, Capell HA. Porter DR, et al. Baillieres Clin Rheumatol. 1990 Dec;4(3):535-51. doi: 10.1016/s0950-3579(05)80006-8. Baillieres Clin Rheumatol. 1990. PMID: 1982707 Review.

7

Non-Hodgkin's lymphoma in rheumatoid arthritis.

Porter D, Madhok R, Capell H. Porter D, et al. Ann Rheum Dis. 1991 May;50(5):275-6. doi: 10.1136/ard.50.5.275. Ann Rheum Dis. 1991. PMID: 2042979 Free PMC article. No abstract available.

8

Effect of patient population characteristics in assessing the efficacy and toxicity of methotrexate in rheumatoid arthritis: comment on the article by Weinblatt et al.

Porter D, Capell H. Porter D, et al. Arthritis Rheum. 1995 Aug;38(8):1173-4. doi: 10.1002/art.1780380824. Arthritis Rheum. 1995. PMID: 7639818 No abstract available.

9

Outcome of second line therapy in rheumatoid arthritis.

Porter DR, McInnes I, Hunter J, Capell HA. Porter DR, et al. Ann Rheum Dis. 1994 Dec;53(12):812-5. doi: 10.1136/ard.53.12.812. Ann Rheum Dis. 1994. PMID: 7864689 Free PMC article. Clinical Trial.

10

The use of serum ferritin estimation in the investigation of anaemia in patients with rheumatoid arthritis.

Porter DR, Sturrock RD, Capell HA. Porter DR, et al. Clin Exp Rheumatol. 1994 Mar-Apr;12(2):179-82. Clin Exp Rheumatol. 1994. PMID: 8039285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,862 results

Search Page

Filters